Literature DB >> 11493279

In vitro and in vivo evaluation of albumin synthesis rate of porcine hepatocytes in a flat-plate bioreactor.

M Shito1, N H Kim, H Baskaran, A W Tilles, R G Tompkins, M L Yarmush, M Toner.   

Abstract

Several configurations of extracorporeal bioartificial liver devices have been developed for the potential treatment of fulminant hepatic failure or as a bridge to liver transplantation. Recently, we developed a microchannel flat-plate bioreactor with an internal membrane oxygenator in which porcine hepatocytes are cultured as a monolayer on the bottom glass surface. In the present study, we investigated synthetic function of porcine hepatocytes in the bioreactor in both in vitro and in vivo flow circuit models. In vitro, albumin synthesis was stable in the bioreactor for up to 4 days of perfusion. In vivo, with the extracorporeal connection of the bioreactor to rat vasculature, porcine albumin was detectable for 24 h in the rat plasma. We also developed a simple mathematical model to predict the in vivo porcine albumin concentration in rat plasma. These results indicate that this configuration of a microchannel flat-plate bioreactor has potential as a liver support device and warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11493279     DOI: 10.1046/j.1525-1594.2001.025007571.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  8 in total

1.  The effectiveness of a novel cartridge-based bioreactor design in supporting liver cells.

Authors:  Mei Niu; Paul Hammond; Robin N Coger
Journal:  Tissue Eng Part A       Date:  2009-10       Impact factor: 3.845

2.  Cell therapeutic options in liver diseases: cell types, medical devices and regulatory issues.

Authors:  Andreas K Nussler; Katrin Zeilinger; Lilianna Schyschka; Sabrina Ehnert; Jörg C Gerlach; Xueying Yan; Serene M L Lee; Maren Ilowski; Wolfgang E Thasler; Thomas S Weiss
Journal:  J Mater Sci Mater Med       Date:  2011-04-03       Impact factor: 3.896

3.  Treatment of fulminant hepatic failure in rats using a bioartificial liver device containing porcine hepatocytes producing interleukin-1 receptor antagonist.

Authors:  Masahiro Shinoda; Arno W Tilles; Go Wakabayashi; Atsushi Takayanagi; Hirohisa Harada; Hideaki Obara; Kazuhiro Suganuma; François Berthiaume; Motohide Shimazu; Nobuyoshi Shimizu; Masaki Kitajima; Ronald G Tompkins; Mehmet Toner; Martin L Yarmush
Journal:  Tissue Eng       Date:  2006-05

4.  A bioartificial liver device secreting interleukin-1 receptor antagonist for the treatment of hepatic failure in rats.

Authors:  Masahiro Shinoda; Arno W Tilles; Naoya Kobayashi; Go Wakabayashi; Atsushi Takayanagi; Toshinori Totsugawa; Hirohisa Harada; Hideaki Obara; Kazuhiro Suganuma; François Berthiaume; Motohide Shimazu; Nobuyoshi Shimizu; Noriaki Tanaka; Masaki Kitajima; Ronald G Tompkins; Mehmet Toner; Martin L Yarmush
Journal:  J Surg Res       Date:  2006-11-01       Impact factor: 2.192

5.  A microfluidic hepatic coculture platform for cell-based drug metabolism studies.

Authors:  Eric Novik; Timothy J Maguire; Piyun Chao; K C Cheng; Martin L Yarmush
Journal:  Biochem Pharmacol       Date:  2009-11-27       Impact factor: 5.858

6.  Modeling nutrient consumptions in large flow-through bioreactors for tissue engineering.

Authors:  Mamatha Devarapalli; Benjamin J Lawrence; Sundararajan V Madihally
Journal:  Biotechnol Bioeng       Date:  2009-08-01       Impact factor: 4.530

7.  Evaluation of a novel choanoid fluidized bed bioreactor for future bioartificial livers.

Authors:  Cheng-Bo Yu; Xiao-Ping Pan; Liang Yu; Xiao-Peng Yu; Wei-Bo Du; Hong-Cui Cao; Jun Li; Ping Chen; Lan-Juan Li
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

8.  Bioengineering the liver: scale-up and cool chain delivery of the liver cell biomass for clinical targeting in a bioartificial liver support system.

Authors:  Eloy Erro; James Bundy; Isobel Massie; Sherri-Ann Chalmers; Aude Gautier; Spyridon Gerontas; Mike Hoare; Peter Sharratt; Sarah Choudhury; Marcin Lubowiecki; Ian Llewellyn; Cécile Legallais; Barry Fuller; Humphrey Hodgson; Clare Selden
Journal:  Biores Open Access       Date:  2013-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.